Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations:
Systematic examination for diagnostic features:
Systematic examination:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (seizures / developmental delay / skin lesions). On examination, the child appears _____ (well/unwell), with _____ (facial angiofibromas / macrocephaly). Skin: ash‑leaf spots _____ (present/absent), facial angiofibromas _____ (present/absent), shagreen patch _____ (present/absent). Head circumference: _____ cm (_____ percentile). Eye findings: retinal hamartomas _____ (present/absent), fundi _____ (normal / hamartomas). Neurological exam: tone _____, reflexes _____, plantars _____. Growth: weight _____ percentile, height _____ percentile. Associated signs: _____ (cardiac rhabdomyomas, renal angiomyolipomas).
• Neurofibromatosis type 1 – café‑au‑lait spots, neurofibromas.
• Sturge‑Weber syndrome – port‑wine stain, leptomeningeal angioma.
• Hypomelanosis of Ito – hypopigmented whorls, neurological involvement.
• Linear nevus sebaceous syndrome – linear nevi, seizures.
• Incontinentia pigmenti – pigmented skin lesions, CNS involvement.
• Focal cortical dysplasia – focal seizures, no skin lesions.
• Infantile spasms (other causes) – no skin or systemic features.
• Isolated angiofibromas – no other features.
• Isolated renal angiomyolipomas – may be sporadic.
• Familial macrocephaly – no skin or systemic features.
• Brain MRI – cortical tubers, subependymal nodules, SEGAs, white matter abnormalities.
• Wood's lamp examination – hypopigmented macules.
• Genetic testing – TSC1 (hamartin) or TSC2 (tuberin) mutations.
• Ophthalmoscopy – retinal hamartomas.
• Genetic testing – TSC1/TSC2 – confirms diagnosis.
• Parental examination – to identify familial cases.
• Prenatal testing – if family history.
• Detailed family history – for autosomal dominant inheritance.
• EEG – hypsarrhythmia (infantile spasms), focal discharges.
• Echocardiography – cardiac rhabdomyomas.
• Renal ultrasound – angiomyolipomas, cysts.
• Chest CT – lymphangioleiomyomatosis (if >18 yrs, female).
• Ophthalmology – retinal hamartomas.
• MRI brain – monitor for SEGA growth (1‑3 yearly).
• Renal ultrasound – monitor angiomyolipoma growth.
• Echocardiography – monitor rhabdomyomas (may regress).
• EEG – if seizures / infantile spasms.
• Ophthalmology – regular retinal exams.
• Developmental assessment – monitor for intellectual disability, autism.
🔹 Management – Across Organ Systems
Seizures: vigabatrin (infantile spasms), AEDs (focal seizures). mTOR inhibitors (everolimus) for refractory seizures.
SEGA: monitoring, surgical resection, everolimus (reduces size).
Angiomyolipomas: monitoring, mTOR inhibitors (everolimus), embolization, surgery (if large/bleeding).
Rhabdomyomas: monitor; may regress. Treat heart failure/arrhythmias if symptomatic.
Early intervention, physiotherapy, OT, speech therapy, behavioural therapy (autism).
Angiofibromas: topical rapamycin/sirolimus, laser therapy.
LAM (lymphangioleiomyomatosis): sirolimus, pulmonary function monitoring (if >18 yrs, female).
Recurrence risk (50% if parent affected, new mutation ~70%). Prenatal diagnosis.
📈 Prognosis
📋 Follow‑up Schedule